Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso)

Cissé, Mamoudou; Sangaré, Ibrahim; Guekoun, Lougué; Bamba, Sanata; Bayane, Dramane; Guiguemdé, Robert Tinga

doi:10.1186/s12879-014-0631-z

Cited by 39 publications

(54 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These results are consistent with those of several authors [3] [7] [22] [23] who believe that parity (first and second pregnancy) constitutes a risk factor for malaria. This is explained by the fact that primigests are less frequently exposed to antibodies to chondroitin sulfate A (CSA] [24].…”

Section: Discussionsupporting

confidence: 93%

“…This result is similar to those of two studies conducted in Burkina-Faso by the teams of Cissé [3] and Ouédraogo [15] who respectively found a prevalence of malaria on pregnancy of 18.2% and 18.6%. On the other hand, the difference is clearly observed with the results of various other authors: 42.6% and 56.4% respectively for Dako-Gueke and Kofie [9] in two different environments in Ghana as well as 42.6% for Tahita and collaborators [16] in Burkina Faso and 41.6% for Fana and allies (10] in Nigeria.…”

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Epidemiological Aspects of Malaria in Pregnant Women: Prevalence and Risk Factors in Mwene Ditu, DR Congo

Jean-Claude¹,

Bienfait²,

Simon³

et al. 2018

OALib

View full text Add to dashboard Cite

Introduction: Malaria in pregnancy induces significant risks for the mother and the foetus. The objective of this study was to determine the prevalence of malaria and the risk factors among pregnant women in the Health District of Mwene Ditu in DR Congo.Methods: A cross-sectional descriptive study based on household survey was carried out in June 2016 in the Health District of Mwene Ditu. The calculated sample size was 461 pregnant women selected through a stratified random sampling. A structured interview using a pre-established questionnaire was administered to and peripheral blood samples were collected for laboratory tests in all pregnant women presenting malaria symptoms or fever history. The following statistics were used: Chi square test and Odds ratio with a confidence interval at 95%.Results The prevalence of malaria in pregnant women was 14.97%. The following parameters proved to be risk factors for malaria illness in pregnant women in Mwene Ditu: low socio-economic level of the couple [AOR = 6.48 (1.51; 27.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussionsupporting

confidence: 90%

Epidemiological Aspects of Malaria in Pregnant Women: Prevalence and Risk Factors in Mwene Ditu, DR Congo

Jean-Claude¹,

Bienfait²,

Simon³

et al. 2018

OALib

View full text Add to dashboard Cite

show abstract

“…This is in agreement with a study conducted in Burkina-Faso where pregnant women with more than 3 ANC visits were found to be 1.3 times more likely to have malaria [22]. The frequent visits by the pregnant women in the current study might be due to ill health, which required thatthey returned to the ANC for review.…”

Section: Discussionsupporting

confidence: 80%

Prevalenceof malaria and anaemiaamong pregnant women attending Antenatal Care Clinic in the Hohoe Municipality of Ghana

Kweku

Ofori

Takramah

et al. 2017

IJND

View full text Add to dashboard Cite

Background:Malaria infection during pregnancy is a major public health problem in the tropical and sub-tropical regions. This study determined the prevalence and factors associated with malaria and anaemia among pregnant women. Methods: A cross-sectional hospital-based study carried out from January to December 2016at the Hohoe Municipal Hospital. Pregnant women of all gravidities with gestational agebetween16-37weeks, attending focused antenatal care (Focused-ANC) were interviewed using asemi-structured questionnaire to obtainsociodemographic, obstetric and medical history data. Blood samples were examined for Hemoglobin levels and malaria parasitaemia. Chi-square test and logistic regression were used to determine the association between dependent and independent variables. Linear regression was used to determine the association between the risk factors of the covariates and the log parasite density. A P-value <0.05 was considered as statistically significant. Results: Of 1200 women, malariaparasitaemia was present in 244 (20.3%), anaemia (Hb<11.0 g ⁄dl) in724 (60.3%).Ownership and usage of long-lasting insecticide treatednet(LLIN) were95.3% and 86.5% respectively. Women who were anaemic and those who visited focused-ANC 5-8 times were 1.70 and 2.08 times more likely to have malaria, (AOR=1.70, p<0.001)and (AOR=2.06, p=0.039) respectively. Women in their 3 rd trimester were 41% times less likely to have malaria (AOR=0.59, p=0.033).Women aged between 30-39 years and those who took ≥ 3 doses of Sulphadoxine -pyrimethamine (SP-IPTp)were 42% and 54% times less likely to have anaemia [AOR=0.58; p=0.040] and[AOR=0.46; p=0.010] respectively. Women in their2 nd trimester were 1.39 times more likely to have anaemia [AOR=1.39; p=0.043]. Parasite density decreased with increasing age (r=-0.041, p=0.033).Conclusion: One out of every 5 pregnant women had malaria and 6 out of every 10 pregnant women had anaemia. Administration of ≥ 3 doses of SP-IPTp reduces anaemia. The presence of malaria results in anaemia and makes pregnant women increase the number of Focused-ANC visits. Age is arisk factor for parasite density. With the high prevalence, targeted interventions for younger women and women in their 2 nd trimesterare needed to reduce anaemiain pregnancy within Hohoe Municipality of Ghana.

show abstract

“…Details for these two cross-sectional studies including samples collection have been described elsewhere [19, 20]. Briefly, during these studies, all pregnant women presenting for routine ANC or delivery were consecutively recruited at the primary health facilities of Kua and Lafiabougou (both located in the peri-urban area of Bobo-Dioulasso).…”

Section: Methodsmentioning

confidence: 99%

Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso

Cissé

Awandare

Soulama

et al. 2017

Malar J

Self Cite

View full text Add to dashboard Cite

BackgroundThe impact of sulfadoxine–pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso. This study sought first to explore the relationship between IPTp-SP and the presence of mutant parasites. Second, to assess the relationship between the mutant parasites and adverse pregnancy outcomes.Methods From September to December 2010, dried blood spots (DBS) were collected during antenatal care visits and at delivery from 109 pregnant women with microscopically confirmed falciparum malaria infection. DBS were analysed by PCR–restriction fragment length polymorphism (PCR–RFLP) for the polymorphisms at codons 51, 59, 108, and 164 of the Pfdhfr gene and codons 437 and 540 in the Pfdhps gene.ResultsBoth the Pfdhfr and Pfdhps genes were successfully genotyped in 92.7% (101/109) of the samples. The prevalence of Pfdhfr mutations N51I, C59R and S108N was 71.3, 42.6 and 64.4%, respectively. Overall, 80.2% (81/101) of samples carried the Pfdhps A437G mutation. None of the samples had the Pfdhfr I164L and the Pfdhps K540E mutations. The prevalence of the triple mutation N51I + C59R + S108N was 25.7% (26/101). The use of IPTp-SP was associated with a threefold increased odds of Pfdhfr C59R mutation [crude OR 3.29; 95% CI (1.44–7.50)]. Pregnant women with recent uptake of IPTp-SP were at higher odds of both the Pfdhfr C59R mutation [adjusted OR 4.26; 95% CI (1.64–11.07)] and the Pfdhfr intermediate-to-high resistance, i.e., ≥ 2 Pfdhfr mutations [adjusted OR 3.45; 95% CI (1.18–10.07)]. There was no statistically significant association between the presence of the Pfdhfr intermediate-to-high resistance and parasite densities or both maternal haemoglobin level and anaemia.ConclusionThe data indicate that despite the possibility that IPTp-SP contributes to the selection of resistant parasites, it did not potentiate pregnancy-associated malaria morbidity, suggesting the continuation of SP use as IPTp in Burkina Faso.Electronic supplementary materialThe online version of this article (doi:10.1186/s12936-017-1695-1) contains supplementary material, which is available to authorized users.

show abstract

Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso)

Cited by 39 publications

References 33 publications

Epidemiological Aspects of Malaria in Pregnant Women: Prevalence and Risk Factors in Mwene Ditu, DR Congo

Epidemiological Aspects of Malaria in Pregnant Women: Prevalence and Risk Factors in Mwene Ditu, DR Congo

Prevalenceof malaria and anaemiaamong pregnant women attending Antenatal Care Clinic in the Hohoe Municipality of Ghana

Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso

Contact Info

Product

Resources

About